Zobrazeno 1 - 10
of 15
pro vyhledávání: '"M. Cecilia Crisanti"'
Autor:
Steven M. Albelda, Linda A. Snyder, Daniel Heitjan, Liang-Chuan S. Wang, M. Cecilia Crisanti, Sunil Singhal, Jing Sun, Guanjun Cheng, Veena Kapoor, George Buchlis, Zvi G. Fridlender
Supplementary Table 1 from CCL2 Blockade Augments Cancer Immunotherapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4fbbc3752c3b5855e1c934f3154cc098
https://doi.org/10.1158/0008-5472.22382091
https://doi.org/10.1158/0008-5472.22382091
Autor:
Steven M. Albelda, Linda A. Snyder, Daniel Heitjan, Liang-Chuan S. Wang, M. Cecilia Crisanti, Sunil Singhal, Jing Sun, Guanjun Cheng, Veena Kapoor, George Buchlis, Zvi G. Fridlender
Altering the immunosuppressive microenvironment that exists within a tumor will likely be necessary for cancer vaccines to trigger an effective antitumor response. Monocyte chemoattractant proteins (such as CCL2) are produced by many tumors and have
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b7d86ae4e7e6dca427fffee9a7f8deaf
https://doi.org/10.1158/0008-5472.c.6500100.v1
https://doi.org/10.1158/0008-5472.c.6500100.v1
Autor:
Steven M. Albelda, Linda A. Snyder, Daniel Heitjan, Liang-Chuan S. Wang, M. Cecilia Crisanti, Sunil Singhal, Jing Sun, Guanjun Cheng, Veena Kapoor, George Buchlis, Zvi G. Fridlender
Supplementary Figure Legend 1 from CCL2 Blockade Augments Cancer Immunotherapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ae781e96c8eecf3ed14b457838cbb0c
https://doi.org/10.1158/0008-5472.22382097
https://doi.org/10.1158/0008-5472.22382097
Autor:
Steven M. Albelda, Linda A. Snyder, Daniel Heitjan, Liang-Chuan S. Wang, M. Cecilia Crisanti, Sunil Singhal, Jing Sun, Guanjun Cheng, Veena Kapoor, George Buchlis, Zvi G. Fridlender
Supplementary Figure 2 from CCL2 Blockade Augments Cancer Immunotherapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08cd7c9df3087dee32f89c512d8a8b35
https://doi.org/10.1158/0008-5472.22382100
https://doi.org/10.1158/0008-5472.22382100
Autor:
Steven M. Albelda, Linda A. Snyder, Daniel Heitjan, Liang-Chuan S. Wang, M. Cecilia Crisanti, Sunil Singhal, Jing Sun, Guanjun Cheng, Veena Kapoor, George Buchlis, Zvi G. Fridlender
Supplementary Figure 1 from CCL2 Blockade Augments Cancer Immunotherapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6232dcc8cafe98805039dca7ef7c870c
https://doi.org/10.1158/0008-5472.22382103
https://doi.org/10.1158/0008-5472.22382103
Autor:
Steven M. Albelda, Linda A. Snyder, Daniel Heitjan, Liang-Chuan S. Wang, M. Cecilia Crisanti, Sunil Singhal, Jing Sun, Guanjun Cheng, Veena Kapoor, George Buchlis, Zvi G. Fridlender
Supplementary Figure Legend 2 from CCL2 Blockade Augments Cancer Immunotherapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a02f6d348afb84dbb111e116a427c0d
https://doi.org/10.1158/0008-5472.22382094
https://doi.org/10.1158/0008-5472.22382094
Autor:
Linda A. Snyder, Sunil Singhal, Steven M. Albelda, Daniel F. Heitjan, George Buchlis, M. Cecilia Crisanti, Jing Sun, Veena Kapoor, Liang-Chuan S. Wang, Guanjun Cheng, Zvi G. Fridlender
Publikováno v:
Cancer Research. 70:109-118
Altering the immunosuppressive microenvironment that exists within a tumor will likely be necessary for cancer vaccines to trigger an effective antitumor response. Monocyte chemoattractant proteins (such as CCL2) are produced by many tumors and have
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44f5f1bc91141f20ac82b06216ab0c5f
https://doi.org/10.1158/0008-5472.can-09-2326
https://doi.org/10.1158/0008-5472.can-09-2326
Autor:
Mark J. Mondrinos, Honesto Poblete, M. Cecilia Crisanti, Christine Finck, Sirma H. Koutzaki, Peter I. Lelkes
Publikováno v:
Tissue Engineering Part A. 14:361-368
Intrapulmonary engraftment of engineered lung tissues could provide a potential therapeutic approach for the treatment of pediatric and adult pulmonary diseases. In working toward this goal, we report here on in vivo generation of vascularized pulmon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ace89d4f3d7934c963cd3c8706ef3a1f
https://doi.org/10.1089/tea.2007.0041
https://doi.org/10.1089/tea.2007.0041
Autor:
Lucas Willems, Fabian Vandermeers, Céline Mascaux, Arsène Burny, Veena Kapoor, Steven M. Albelda, Roland Hubaux, M. Cecilia Crisanti
Publikováno v:
European journal of cancer (Oxford, England : 1990). 46(9)
Prognosis of small cell lung carcinoma (SCLC) is particularly poor, less than 5% of patients with extensive stage being alive after two years. We hypothesized that SCLC chemotherapy could be improved by using histone deacetylase (HDAC) inhibitors bas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ae1d818ccff4caf0b56805ab4579123
https://pubmed.ncbi.nlm.nih.gov/20451370
https://pubmed.ncbi.nlm.nih.gov/20451370
Autor:
M. Cecilia Crisanti, Kara Coleman, Steven M. Albelda, Fabian Vandermeers, Luana Pereira, Barbara G. Campling, Zvi G. Fridlender, Africa F. Wallace, Melissa L. Dowling, Gary D. Kao, Veena Kapoor
Lung cancer is the leading cause of cancer deaths in the United States. Current therapies are inadequate. Histone deacetylase inhibitors (HDACi) are a recently developed class of anticancer agents that cause increased acetylation of core histones and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::257467012e652161c9ccb6c5da178a35
https://europepmc.org/articles/PMC3605895/
https://europepmc.org/articles/PMC3605895/